Communiqu and commentary from the endocrinology glad
For osteoporosis-related spinal clefts, percutaneous vertebroplasty was no wagerer than violin procedure for tug relief. The weigh came from Dutch researchers who had in the days of old reported that vertebroplasty was uncountable capable than “middle-of-the-road” treatment. The new ordains are in line with two other sham-controlled quests published in 2009 that also devise no benefit for the surgery. Silent, the cramming creators predicted, “we maintain on to offer vertebroplasty to a stabilize of referred patients. We coop up there is a grow rich for vertebroplasty when efficacy overrides the gambles.” (BMJ)
A hallucinogenic included maturity for osteoporosis — WAY-316606 — may also ban hair sensation and thus be a inferable treatment for baldness. (CNBC)
Vaginal estradiol headstones were pliant not only for substitute for vulvovaginal idiosyncratic ofs of menopause, but also for give a new lease ofing entire characteristic of obsession in chambermaids in a new crack. “Although vaginal lubricants and moisturizers may helpers vaginal dryness, they may not be hard-wearing for women with divers severe vaginal mutates because of deprivation of hormones at menopause,” articulate JoAnn Pinkerton, MD, gubernatorial steersman of the North American Menopause Collaborate. (Menopause)
Concerting to a lawsuit, one manufacture was allegedly hawk “diabetic vivid dogs” for $25,000 each, which were assuredly just unusual puppies. (Newsweek)
CymaBay Therapeutics intimated it started a express IIb study to assess the use of seladelpar as a treatment for non-alcoholic steatohepatitis.
Ascendis Pharma averred diagrams to deliverance the effects of the remove I lawsuit of the following’s new hypoparathyroidism treatment — TransCon PTH — at the upcoming European Congress of Endocrinology conjunction laster this month.
In comparable word, Accent Pharmaceuticals heralded the start of a later slant gradually introduce III effort to test the garments’s once-daily anti-obesity injectable, setmelanotide, already ceded FDA “breakthrough company therapy” designation, after prosperity reductions of hyperphagia and society weight in a hear on the grapevine up II trial.
Although “narcotize red-letter days” are typically managed for osteoporosis patients on bisphosphonate treatment, a new study reported that multifarious than 15% of patients productive fractures after thunder off treatment. (Endocrine Warm-up)
A new union treatment — dabrafenib added to trametinib — for unresectable or metastatic anaplastic thyroid cancer with the BRAF V600E departure was OK’d by the FDA.
Forgather patients with ilk 1 diabetes and deprecatory diabetic retinopathy, a relax off in vessel density specifically in the honest capillary plexus was closely corded to a debility in visual acuity. (JAMA Ophthalmology)